<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02251665</url>
  </required_header>
  <id_info>
    <org_study_id>NationalCardioCenter</org_study_id>
    <nct_id>NCT02251665</nct_id>
  </id_info>
  <brief_title>National Cerebral and Cardiovascular Center (NCVC) Stroke Registry</brief_title>
  <official_title>National Cerebral and Cardiovascular Center (NCVC) Stroke Registry</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Cerebral and Cardiovascular Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Cerebral and Cardiovascular Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A single-center registry of patients with acute ischemic stroke, intracerebral hemorrhage,
      and transient ischemic attack (TIA) who are emergently managed in the stroke care unit in the
      National Cerebral and Cardiovascular Center (NCVC) to determine change in underlying
      characteristics, stroke features and severity, process for diagnosis and acute treatment, and
      long-term outcomes of stroke/TIA patients over the years.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a single-center registry of consecutive patients with acute ischemic stroke,
      intracerebral hemorrhage, and transient ischemic attack (TIA) who are emergently managed in
      the stroke care unit in the National Cerebral and Cardiovascular Center, a flagship stroke
      center in Japan.

      Neurological emergencies other than stroke/TIA and subclinical cerebrobvascular inpatients
      are also enrolled.

      Data are collected and analyzed to determine change in underlying characteristics, stroke
      features and severity, process for diagnosis and acute treatment, and long-term outcomes of
      stroke/TIA patients over the years.

      The National Cerebral and Cardiovascular Center was founded in 1977 in Suita, Osaka, in order
      to provide the public with the most advanced treatment for cardiovascular and cerebrovascular
      diseases and to conduct the highest level of basic as well as applied research on the
      cardiovascular and cerebrovascular systems.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2011</start_date>
  <completion_date type="Anticipated">March 2025</completion_date>
  <primary_completion_date type="Anticipated">March 2025</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>The modified Rankin Scale (mRS), a measure of disability</measure>
    <time_frame>3 monhts</time_frame>
    <description>mRS scores range from 0 (no symptoms at all) to 6 (death)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of participants</measure>
    <time_frame>at entry</time_frame>
    <description>Also assessing underlying patients' characteristics prior to index stroke/TIA</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>National Institutes of Health Stroke Scale score</measure>
    <time_frame>at entry</time_frame>
    <description>Also assessing neurological and cognitive states</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Volume of culprit infarcts/hematoma</measure>
    <time_frame>at entry</time_frame>
    <description>ASPECTS on DWI for ischemia or hematoma volume using the ABC/2 method</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The modified Rankin Scale (mRS), a measure of disability</measure>
    <time_frame>around 3 weeks</time_frame>
    <description>mRS scores range from 0 (no symptoms at all) to 6 (death). Participants will be followed at hospital discharge, an expected average of 3 weeks.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The modified Rankin Scale (mRS), a measure of disability</measure>
    <time_frame>1 year</time_frame>
    <description>mRS scores range from 0 (no symptoms at all) to 6 (death)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Events of cardiovascular diseases including stroke/TIA</measure>
    <time_frame>around 3 weeks</time_frame>
    <description>Participants will be followed at hospital discharge, an expected average of 3 weeks.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Events of cardiovascular diseases including stroke/TIA</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Events of cardiovascular diseases including stroke/TIA</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">6000</enrollment>
  <condition>Stroke, Acute</condition>
  <arm_group>
    <arm_group_label>Acute ischemic stroke, acute ICH, TIA</arm_group_label>
    <description>Consecutive patients with acute ischemic stroke, intracerebral hemorrhage, and transient ischemic attack who are emergently managed in the stroke care unit or stroke units in the National Cerebral and Cardiovascular Center</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>No intervention</intervention_name>
    <description>a single-center prospective observational study</description>
    <arm_group_label>Acute ischemic stroke, acute ICH, TIA</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Inpatients
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. A patient with acute ischemic stroke, intracerebral hemorrhage, and transient ischemic
             attack who are emergently managed in the stroke care unit or stroke units in the
             National Cerebral and Cardiovascular Center (NCVC)

          2. Consent to participate in the registration by a patient or relatives obtained using an
             opt-out approach by the demonstrating contents of the registration on the hospital
             bulletin board

        Exclusion Criteria:

        1) Patients considered by the investigator to be unsuitable for participating in this
        registry
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kazunori Toyoda, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Director and Chair, Dept. of Stroke and Cerebrovascular Diseases, National Cerebral and Cardiovascular Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kazunori Toyoda, MD, PhD</last_name>
    <email>toyoda@ncvc.go.jp</email>
  </overall_contact>
  <location>
    <facility>
      <name>National Cerebral and Cardiovascular Center</name>
      <address>
        <city>Suita</city>
        <state>Osaka</state>
        <zip>565-8565</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kazunori Toyoda, MD, PhD</last_name>
      <email>toyoda@ncvc.go.jp</email>
    </contact>
  </location>
  <location_countries>
    <country>Japan</country>
  </location_countries>
  <link>
    <url>http://www.ncvc.go.jp/english/index.html</url>
    <description>Official home page of the National Cerebral and Cardiovascular Center</description>
  </link>
  <results_reference>
    <citation>Toyoda K, Ninomiya T. Stroke and cerebrovascular diseases in patients with chronic kidney disease. Lancet Neurol. 2014 Aug;13(8):823-33. doi: 10.1016/S1474-4422(14)70026-2. Review.</citation>
    <PMID>25030514</PMID>
  </results_reference>
  <results_reference>
    <citation>Osaki M, Miyashita F, Koga M, Fukuda M, Shigehatake Y, Nagatsuka K, Minematsu K, Toyoda K. Simple clinical predictors of stroke outcome based on National Institutes of Health Stroke scale score during 1-h recombinant tissue-type plasminogen activator infusion. Eur J Neurol. 2014 Mar;21(3):411-8. doi: 10.1111/ene.12294. Epub 2013 Nov 7.</citation>
    <PMID>24200315</PMID>
  </results_reference>
  <results_reference>
    <citation>Sakamoto Y, Sato S, Kuronuma Y, Nagatsuka K, Minematsu K, Toyoda K. Factors associated with proximal carotid axis occlusion in patients with acute stroke and atrial fibrillation. J Stroke Cerebrovasc Dis. 2014 May-Jun;23(5):799-804. doi: 10.1016/j.jstrokecerebrovasdis.2013.07.002. Epub 2013 Oct 6.</citation>
    <PMID>24103668</PMID>
  </results_reference>
  <results_reference>
    <citation>Sato S, Uehara T, Hayakawa M, Nagatsuka K, Minematsu K, Toyoda K. Intra- and extracranial atherosclerotic disease in acute spontaneous intracerebral hemorrhage. J Neurol Sci. 2013 Sep 15;332(1-2):116-20. doi: 10.1016/j.jns.2013.06.031. Epub 2013 Jul 13.</citation>
    <PMID>23859180</PMID>
  </results_reference>
  <results_reference>
    <citation>Kobayashi J, Uehara T, Toyoda K, Endo K, Ohara T, Fujinami J, Nagatsuka K, Minematsu K. Clinical significance of fluid-attenuated inversion recovery vascular hyperintensities in transient ischemic attack. Stroke. 2013 Jun;44(6):1635-40. doi: 10.1161/STROKEAHA.111.000787. Epub 2013 May 7.</citation>
    <PMID>23652273</PMID>
  </results_reference>
  <results_reference>
    <citation>Tanaka K, Koga M, Sato K, Suzuki R, Minematsu K, Toyoda K. Three-dimensional analysis of the left atrial appendage for detecting paroxysmal atrial fibrillation in acute ischemic stroke. Int J Stroke. 2014 Dec;9(8):1045-51. doi: 10.1111/ijs.12268. Epub 2014 Mar 13.</citation>
    <PMID>24621380</PMID>
  </results_reference>
  <results_reference>
    <citation>Tomii Y, Toyoda K, Suzuki R, Naganuma M, Fujinami J, Yokota C, Minematsu K. Effects of 24-hour blood pressure and heart rate recorded with ambulatory blood pressure monitoring on recovery from acute ischemic stroke. Stroke. 2011 Dec;42(12):3511-7. doi: 10.1161/STROKEAHA.111.628586. Epub 2011 Sep 29.</citation>
    <PMID>21960578</PMID>
  </results_reference>
  <results_reference>
    <citation>Koga M, Arihiro S, Miyashita F, Yamamoto H, Yamada N, Nagatsuka K, Minematsu K, Toyoda K. Factors associated with early recanalization failure following intravenous rt-PA therapy for ischemic stroke. Cerebrovasc Dis. 2013;36(4):299-305. doi: 10.1159/000355054. Epub 2013 Oct 16.</citation>
    <PMID>24135558</PMID>
  </results_reference>
  <results_reference>
    <citation>Inoue Y, Miyashita F, Koga M, Minematsu K, Toyoda K. Unclear-onset intracerebral hemorrhage: Clinical characteristics, hematoma features, and outcomes. Int J Stroke. 2017 Dec;12(9):961-968. doi: 10.1177/1747493017702664. Epub 2017 Mar 31.</citation>
    <PMID>28361615</PMID>
  </results_reference>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 23, 2014</study_first_submitted>
  <study_first_submitted_qc>September 25, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 29, 2014</study_first_posted>
  <last_update_submitted>March 29, 2018</last_update_submitted>
  <last_update_submitted_qc>March 29, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 2, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>National Cerebral and Cardiovascular Center</investigator_affiliation>
    <investigator_full_name>Kazunori Toyoda</investigator_full_name>
    <investigator_title>Director and Chair, Dept. of Stroke and Cerebrovascular Diseases</investigator_title>
  </responsible_party>
  <keyword>Acute ischemic stroke</keyword>
  <keyword>Acute intracerebral hemorrhage</keyword>
  <keyword>Transient ischemic attack</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

